From NPR's On Point. By Paige Sutherland and Deborah Becker. Teaser/Abstract "With more than 60% of Americans taking a prescription drug, there are increasing questions about how these medicines are approved, how they're kept safe and how they're priced. In a new book, Harvard's Dr. Jerry Avorn argues the drugs we take have been compromised by profits." Source: On Point with Meghna Chakrabarti, WBUR Boston, April 21, 2025. Host: Deborah Becker. Duration: 45 minutes 32 seconds

From the New England Journal of Medicine. By Pieter A. Cohen, MD; Jerry Avorn, MD; Aaron S. Kesselheim, MD, JD, MPH. SUMMARY: This NEJM Perspective critically evaluates the Dietary Supplement Listing Act of 2022, arguing that the bill would create an appearance of regulatory reform while leaving the core problems of supplement oversight unresolved. The authors — Cohen, Avorn, and Kesselheim — contend that the Act's listing requirement would be largely symbolic, providing regu